Ghate, Alspaugh: "Adalimumab in the management of palmoplantar psoriasis." in: Journal of drugs in dermatology : JDD, Vol. 8, Issue 12, pp. 1136-9, 2009 (PubMed).
Jürgens, Brand, Filik et al.: "Safety of adalimumab in Crohn's disease during pregnancy: case report and review of the literature." in: Inflammatory bowel diseases, Vol. 16, Issue 10, pp. 1634-6, 2010 (PubMed).
Murphy, Schmidt-Martin, Hynes et al.: "Systemic listeriosis with adalimumab therapy." in: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, Vol. 15, Issue 7, pp. 369-70, 2009 (PubMed).
Martorell-Calatayud, Balmer, Cardenas Cardona et al.: "Interstitial granulomatous drug reaction to adalimumab." in: The American Journal of dermatopathology, Vol. 32, Issue 4, pp. 408-9, 2010 (PubMed).
Mease, Signorovitch, Yu et al.: "Impact of adalimumab on symptoms of psoriatic arthritis in patients with moderate to severe psoriasis: a pooled analysis of randomized clinical trials." in: Dermatology (Basel, Switzerland), Vol. 220, Issue 1, pp. 1-7, 2010 (PubMed).
Wetter, Davis: "Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic." in: Mayo Clinic proceedings, Vol. 84, Issue 11, pp. 979-84, 2009 (PubMed).
Borrás-Blasco, Navarro-Ruiz, Borrás et al.: "Adverse cutaneous reactions induced by TNF-alpha antagonist therapy." in: Southern medical journal, Vol. 102, Issue 11, pp. 1133-40, 2009 (PubMed).
Patel: "Systemic sarcoidosis with bone marrow involvement responding to therapy with adalimumab: a case report." in: Journal of medical case reports, Vol. 3, pp. 8573, 2009 (PubMed).
de Vries, Brouwer, van der Horst-Bruinsma et al.: "Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation." in: Annals of the rheumatic diseases, Vol. 68, Issue 11, pp. 1787-8, 2009 (PubMed).
Murdaca, Colombo, Puppo: "Anti-TNF-alpha inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events." in: International journal of immunopathology and pharmacology, Vol. 22, Issue 3, pp. 557-65, 2009 (PubMed).
Turner, Picot, Cooper et al.: "Adalimumab for the treatment of psoriasis." in: Health technology assessment (Winchester, England), Vol. 13 Suppl 2, pp. 49-54, 2009 (PubMed).
Varani, Massara, Vincenzi et al.: "Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate." in: Arthritis and rheumatism, Vol. 60, Issue 10, pp. 2880-91, 2009 (PubMed).
Yildiz, Alkan, Ardic et al.: "Successful treatment with adalimumab in a patient with coexisting Behçet's disease and ankylosing spondylitis." in: Rheumatology international, Vol. 30, Issue 11, pp. 1511-4, 2010 (PubMed).
Tong, Eather, Manolios: "Psoriatic arthritis and chronic lymphoedema: treatment efficacy by adalimumab." in: Clinical rheumatology, Vol. 28, Issue 11, pp. 1349-50, 2009 (PubMed).
Bradford, Pettit, Wright et al.: "Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors." in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 49, Issue 6, pp. 924-7, 2009 (PubMed).
Barreiro-de Acosta, Lorenzo, Dominguez-Muñoz: "Adalimumab in ulcerative colitis: two cases of mucosal healing and clinical response at two years." in: World journal of gastroenterology : WJG, Vol. 15, Issue 30, pp. 3814-6, 2009 (PubMed).
Karmiris, Paintaud, Noman et al.: "Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's disease." in: Gastroenterology, Vol. 137, Issue 5, pp. 1628-40, 2009 (PubMed).
Papadakis, Shaye, Vasiliauskas et al.: "Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab." in: The American journal of gastroenterology, Vol. 100, Issue 1, pp. 75-9, 2005 (PubMed).
Sandborn: "Strategies for targeting tumour necrosis factor in IBD." in: Best practice & research. Clinical gastroenterology, Vol. 17, Issue 1, pp. 105-17, 2003 (PubMed).
Taylor: "Anti-TNFalpha therapy for rheumatoid arthritis: an update." in: Internal medicine (Tokyo, Japan), Vol. 42, Issue 1, pp. 15-20, 2003 (PubMed).
Weinblatt, Keystone, Furst et al.: "Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial." in: Arthritis and rheumatism, Vol. 48, Issue 1, pp. 35-45, 2003 (PubMed).